Patel, R.; Mathews, J.; Hamm, C.; Kulkarni, S.; Gupta, R.; Opperman, T.; Chiong, J.D.; Nasser, A.
Real-World Experience with CDK4/6 Inhibitors in the First-Line Palliative Setting for HR+/HER2− Advanced Breast Cancer. Curr. Oncol. 2025, 32, 52.
https://doi.org/10.3390/curroncol32010052
AMA Style
Patel R, Mathews J, Hamm C, Kulkarni S, Gupta R, Opperman T, Chiong JD, Nasser A.
Real-World Experience with CDK4/6 Inhibitors in the First-Line Palliative Setting for HR+/HER2− Advanced Breast Cancer. Current Oncology. 2025; 32(1):52.
https://doi.org/10.3390/curroncol32010052
Chicago/Turabian Style
Patel, Ram, John Mathews, Caroline Hamm, Swati Kulkarni, Rasna Gupta, Tarquin Opperman, John Dean Chiong, and Abdullah Nasser.
2025. "Real-World Experience with CDK4/6 Inhibitors in the First-Line Palliative Setting for HR+/HER2− Advanced Breast Cancer" Current Oncology 32, no. 1: 52.
https://doi.org/10.3390/curroncol32010052
APA Style
Patel, R., Mathews, J., Hamm, C., Kulkarni, S., Gupta, R., Opperman, T., Chiong, J. D., & Nasser, A.
(2025). Real-World Experience with CDK4/6 Inhibitors in the First-Line Palliative Setting for HR+/HER2− Advanced Breast Cancer. Current Oncology, 32(1), 52.
https://doi.org/10.3390/curroncol32010052
